Archives: Resources

Review PPD’s anti-corruption policy in English.

An infographic showing the drug development process.

Part two of PPD’s series on precision medicine focuses on the use of biomarkers to accelerate clinical research.

Part three of PPD’s series on precision medicine focuses on the development and regulatory approval of in vitro companion diagnostic devices.

Read articles and presentations that demonstrate the use of cell-based assays in biologics and vaccine development programs.

The next revolution in clinical trial execution is now taking shape in the rapid adoption of “mHealth” technologies—mobile devices ranging from smart phones to wearable health monitoring sensors. Mobile technologies have the potential to make the collection of clinical trial data more accurate, timely and convenient for study subjects.

In this white paper “The mHealth Connection to Advance Clinical Research: Emerging Role of Mobile Health and Digital Technologies to Foster Patient-centric Trials”, learn how current PPD-conducted studies assess the feasibility of wearable data collection devices in clinical trials to achieve focused endpoints and improve the patient experience.

To download the white paper, click the button below or image thumbnail.

PPD Laboratories’ bioanalytical lab conducts customized assay development and validations for branded and generic veterinary pharmaceuticals.

Read a white paper on how PPD supports successful clinical development in urinary incontinence indications.

PPD Laboratories is developing future lab solutions to communicate more efficiently with clients, investigators and clinical trial managers.